Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.79% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NKTR · Jun 30, 2024
NEKTAR THERAPEUTICS. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-094231General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-160.51% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
61.58% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
58.53% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-211.90% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
126.54% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
23.07% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.73%
- Current
- 0.79%
- Delta
- 0.07%
- Previous
- -221.30%
- Current
- -160.51%
- Delta
- 60.79%
- Previous
- 75.04%
- Current
- 61.58%
- Delta
- -13.46%
- Previous
- 60.56%
- Current
- 58.53%
- Delta
- -2.03%
- Previous
- -163.72%
- Current
- -211.90%
- Delta
- -48.19%
- Previous
- 126.66%
- Current
- 126.54%
- Delta
- -0.12%
- Previous
- 27.73%
- Current
- 23.07%
- Delta
- -4.66%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NKTR Fundamental State →Has State · NEKTAR THERAPEUTICS →Transitioned To · NKTR Fundamental State →Transitioned To · NKTR CAPEX_INTENSITY_INCREASED →Transitioned To · NKTR CASH_GENERATION_INCREASED →Transitioned To · NKTR INVENTORY_PRESSURE_DECREASED →Transitioned To · NKTR MARGIN_DECREASED →Transitioned To · NKTR PROFITABILITY_DECREASED →Transitioned To · NKTR R_AND_D_INTENSITY_DECREASED →Transitioned To · NKTR SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.